Growing community of inventors

Horsholm, Denmark

Paul E G Kristjansen

Average Co-Inventor Count = 3.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 124

Paul E G KristjansenCharlotte Albaek Thrue (4 patents)Paul E G KristjansenAnja Molhart Hog (4 patents)Paul E G KristjansenMichael Kragh (1 patent)Paul E G KristjansenCharlotte Albæk Thrue (1 patent)Paul E G KristjansenAnja Mølhart Høg (1 patent)Paul E G KristjansenBjørn Quistorff (1 patent)Paul E G KristjansenPaul E G Kristjansen (6 patents)Charlotte Albaek ThrueCharlotte Albaek Thrue (19 patents)Anja Molhart HogAnja Molhart Hog (4 patents)Michael KraghMichael Kragh (13 patents)Charlotte Albæk ThrueCharlotte Albæk Thrue (2 patents)Anja Mølhart HøgAnja Mølhart Høg (1 patent)Bjørn QuistorffBjørn Quistorff (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Enzon Pharmaceuticals, Inc. (4 from 52 patents)

2. Santaris Pharma A/s (4 from 44 patents)

3. Københavns Universitet (1 from 1 patent)

4. Santaris Pharama A/s (1 from 1 patent)


6 patents:

1. 8785617 - Oligomeric compounds for the modulation of HIF-1A expression

2. 8357670 - Oligomeric compounds for the modulation of HIF-1A expression

3. 8207140 - Oligomeric compounds for the modulation of HIF-1α expression

4. 7846911 - Oligomeric compounds for the modulation of HIF-1alpha expression

5. 7737264 - Oligomeric compounds for the modulation HIF-1α expression

6. 6701171 - Method and apparatus for non-invasive detection of angiogenic and anti-angiogenic activity in living tissue

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…